Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | BAX | Q07812 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | PTPRC | P08575 | 3/20 | 0.43 |
| ▸ | S100A4 | P26447 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11050883 | 0.80 | PTPRC (0.57) | TSHRALDH1A1LMNAMEN1KMT2A | |
| SCHEMBL144190 | 0.77 | ALDH1A1 (0.62) | TSHRALDH1A1ALOX15GPR35TP53 | |
| Bromide SCHEMBL8457695 | 0.75 | ALDH1A1 (0.60) | TSHRALDH1A1ALOX15GPR35TP53 | |
| SCHEMBL27985956 | 0.75 | POLB (0.58) | TSHRALDH1A1HPGDLMNAMEN1 | |
| SCHEMBL11028069 | 0.74 | GPR35 (0.69) | TSHRALDH1A1ALOX15GPR35TP53 | |
| SCHEMBL27401673 | 0.74 | GPR35 (0.54) | TSHRALDH1A1ALOX15GPR35TP53 | |
| SCHEMBL526702 | 0.73 | GPR35 (0.62) | TSHRALDH1A1ALOX15GPR35TP53 | |
| Dinitrophenylene SCHEMBL27691692 | 0.71 | TSHR (0.74) | TSHRALDH1A1ALOX15GPR35TP53 | |
| SCHEMBL31463569 | 0.71 | CYP19A1 (0.57) | LMNAMEN1KMT2A | |
| SCHEMBL30317899 | 0.70 | PTPRC (0.54) | TSHRALDH1A1GPR35TP53HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10043980-B2 | Compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-08-07 | — | — | US | disclosed |
| US-20160293847-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| US-20160293847-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| EP-3075731-A1 | PHENANTHRO[4,5-BCA]FURAN COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2016-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10043980-B2 | Compound and organic light-emitting device including the same | OCIAD1, AOX1, CRY1 | TSHR 3805/4885ALDH1A1 6/4885ALOX15 456/4885 |
| US-20160293847-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | OCIAD1, AOX1, CRY1 | TSHR 3805/4885ALDH1A1 6/4885ALOX15 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.